Randomised Intervention Treatment of Angina (RITA) data support coronary artery bypass graft (CABG) at one year
This article was originally published in Clinica
Patients undergoing percutaneous transluminal coronary angioplasty (PTCA) for symptomatic multivessel coronary disease require significantly more reinterventions and are more likely to suffer angina than those undergoing coronary artery bypass graft (CABG). These are among the findings of the first-year results of CABRI, the Coronary Angioplasty versus Bypass Revascularisation Investigation (see Clinica No 569, p 17).
You may also be interested in...
GNC hires Josh Burris as chief US officer; Clasado BioSciences adds Bellchambers as commercial director; and Barentz plans expansion with Cinven investment.
The House passage of a Democratic bill authorizing the federal government to negotiate drug prices in Medicare has sharpened the debate over how prices feed innovation, but the underlying policy stands little chance of being enacted without a Democratic wave in the next election. Pink Sheet's table highlights the key provisions of HR 3 and other pending pricing legislation.